CerebroStem

CerebroStem is a biotechnology company and a subsidiary of Creative Medical Technology Holdings, focused on developing regenerative therapies for neurological disorders. The company utilizes its proprietary AmnioStem™ platform, which employs amniotic fluid-derived stem cells to promote neurogenesis and modulate immune responses. Its primary development programs target radiation-induced brain injury, stroke, and neurodegenerative conditions such as Parkinson's and Alzheimer's diseases. By leveraging the unique properties of perinatal stem cells, CerebroStem aims to provide non-invasive, disease-modifying treatments for patients with significant unmet medical needs in neurology. The company's research is supported by a network of leading neuroscientists and clinical institutions.